. 2023 Sep 28;39(12):2487–2496. doi: 10.1007/s10554-023-02957-0

Table 1.

Baseline characteristics of participants According to cIMT

Variables	cIMT thickening (925)	cIMT non-thickening (843)	P
Age (years) Male gender, n (%) Hypertension, n (%) Hyperlipidemia, n(%) Stroke, n(%) RDW, % Fasting glucose, mmol/L Systolic BP,mmHg Diastolic BP,mmHg LDL-C, mmol/l HDL-C, mmol/l Total cholesterol, mmol/l RC, mmol/l Triglycerides, mmol/l Non-HDL-C, mmol/l AI	58(53–67) 621(67) 141(15) 19(2) 55(6) 12.9(12.6–13.2) 5.21(4.87–5.69) 136(123–149) 83(75–90) 3.07(2.5–3.63) 1.29(1.07–1.58) 5.13(4.51–5.78) 0.67(0.52–0.86) 1.29(0.95–1.87) 3.8(3.2–4.41) 2.91(2.22–3.72)	52(52–57) 500(59) 68(8) 7(0.8) 24(3) 12.7(12.4–13.1) 4.9(4.5–5.3) 125(115–137) 79(71–87) 2.87(2.4–3.39) 1.33(1.1–1.6) 4.88(4.31–5.56) 0.59(0.42–0.8) 1.22(0.86–1.79) 3.53(2.95–4.14) 2.65(1.98–3.53)	< 0.001 0.001 < 0.001 0.033 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 0.08 < 0.001 0.012 < 0.001 < 0.001

Variables

cIMT thickening (925)

cIMT non-thickening (843)

Age (years)

Male gender, n (%)

Hypertension, n (%)

Hyperlipidemia, n(%)

Stroke, n(%)

RDW, %

Fasting glucose, mmol/L

Systolic BP,mmHg

Diastolic BP,mmHg

LDL-C, mmol/l

HDL-C, mmol/l

Total cholesterol, mmol/l

RC, mmol/l

Triglycerides, mmol/l

Non-HDL-C, mmol/l

58(53–67)

621(67)

141(15)

19(2)

55(6)

12.9(12.6–13.2)

5.21(4.87–5.69)

136(123–149)

83(75–90)

3.07(2.5–3.63)

1.29(1.07–1.58)

5.13(4.51–5.78)

0.67(0.52–0.86)

1.29(0.95–1.87)

3.8(3.2–4.41)

2.91(2.22–3.72)

52(52–57)

500(59)

68(8)

7(0.8)

24(3)

12.7(12.4–13.1)

4.9(4.5–5.3)

125(115–137)

79(71–87)

2.87(2.4–3.39)

1.33(1.1–1.6)

4.88(4.31–5.56)

0.59(0.42–0.8)

1.22(0.86–1.79)

3.53(2.95–4.14)

2.65(1.98–3.53)

< 0.001

0.001

< 0.001

0.033

< 0.001

0.08

< 0.001

0.012

< 0.001

Abbreviations: RDW red cell distribution width,BP blood pressure,HDL-C high-density lipoprotein cholesterol,LDL-C low-density lipoprotein cholesterol,RC remnant cholesterol,AI atherosclerosis index